Abstract:The understanding of the pathogenesis of any disease is the key to effective and specific treatment of the disease.immunoglobulin A (IgA) nephropathy is an autoimmune disease of the kidney.Oxford MEST classification is commonly used to stratify patients according to the severity of the disease.Patients with IgA nephropathy seem to produce anti-GalNAc antibodies against a particularly defective IgA1.This immune complex deposits in the kidneys, leading to a type 3 hypersensitivity reaction which ultimately damages the kidneys.People of a certain genetic background and who experience upregulation of certain defective receptors seem to develop primary IgA nephropathy.Secondary IgA nephropathy could be due to dysbiosis of the microbiota in the gut, compromised gut immunity or other gut pathologies, pulmonary function abnormalities, or amyloidosis.Overproduction of IgA due to plasma cell dyscrasia or reduced clearance of IgA due to liver abnormalities could also be potential causes.Genes that predispose individuals to IgA nephropathy and intestinal abnormalities, such as Celiac disease, seem to overlap and these people tend to have a poorer prognosis and need to be placed on more intensive treatment regimens.IgA Vasculitis seems to be a systemic form of IgA nephropathy, whereby IgA deposits systemically and leads to multiple disease manifestations.Patients in high-risk groups could also be prophylactically screened for the disease and closely monitored by immunohistochemical methods such as an enzyme-linked immunosorbent assay (ELISA) or identified by genetic testing.Currently, the major treatment regimens involve supportive therapy or immunosuppressive therapy which has major side effects.More specific treatment methods such as monoclonal antibodies, immunoglobulin replacement therapy, or low-antigencontent diet could also be looked into as potential treatment options.Stem cell replacement, by way of bone marrow transplant and tonsillectomy, has been suggested as a treatment option in patients with indications.

An overview of early genetic predictors of IgA deficiency

Progress in Pathogenesis of Immunoglobin A Nephropathy

Innate Mechanisms in Selective IgA Deficiency

Monogenic Inborn Errors of Immunity with impaired IgG response to polysaccharide antigens but normal IgG levels and normal IgG response to protein antigens

IgA deficiency destabilizes immunological homeostasis towards intestinal microbiota and increases the risk of systemic immune dysregulation

Genetic regulation of serum IgA levels and susceptibility to common immune, infectious, kidney, and cardio-metabolic traits

Type 2 T-Helper Cell Driven Manifestations of Inborn Errors of Immunity

B-cells absence in patients diagnosed as inborn errors of immunity: a registry-based study

Genetic studies of IgA nephropathy: past, present, and future

What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection.

Inborn errors of immunity in adulthood

IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation

Isotype deficiencies (IgG subclass and selective IgA, IgM, IgE deficiencies)

Delineating the Clinical and Immunologic Characteristics: A Comparative Study of Inborn Errors of Immunity in Adult versus Pediatric Diagnosed

Inborn errors of immunity in Canadian First Nations and Nunavut Inuit Children: the tip of the iceberg

Functional genomics in inborn errors of immunity

Clinical and experimental treatment of primary humoral immunodeficiencies

A case report of a patient with recurrent and severe infections highlighting the importance of considering inborn errors of immunity

New concepts in the generation and functions of IgA

Dysregulation of epigenetic modifications in inborn errors of immunity

Atypical Cutaneous Viral Infections Reveal an Inborn Error of Immunity in 8 Patients